Physiological Functions of the Platelets and the Importance of the Correction of Their Disorders in Acute Coronary Syndrome
- Authors: Bouryachkovskaya L.I.1, Lomakin N.V.2,3, Popov E.G.1, Melkumyants A.M.1,4
-
Affiliations:
- Chazov National Medical Research Center of Cardiology
- Central Clinical Hospital of Presidential Administration
- Russian Medical Academy of Continuous Professional Education of the Ministry of Health
- Moscow Institute of Physics and Technology (National Research University)
- Issue: Vol 54, No 2 (2023)
- Pages: 69-85
- Section: Articles
- URL: https://journals.rcsi.science/0301-1798/article/view/138978
- DOI: https://doi.org/10.31857/S0301179823020029
- EDN: https://elibrary.ru/PLBXMS
- ID: 138978
Cite item
Abstract
Abstract—
Platelets play a key role in the development of thrombosis and inflammation. These cells are the key participants in pathological thrombosis due to their ability to attach to damaged areas of blood vessels and further accumulation at the sites of damage. Although platelet activation and adhesion should be considered as a physiological response to a sudden rupture of an atherosclerotic plaque, which frequently contributes to its repair, the uncontrolled progression of such a process in the coronary arteries may result in the formation of a thrombus occluding the lumen of the vessel, that cause the development of myocardial infarction. This review is mainly devoted to the consideration of the correction of platelet function using antiplatelet drugs, which have led to significant positive changes in the fight against acute coronary syndrome and myocardial infarction.
About the authors
L. I. Bouryachkovskaya
Chazov National Medical Research Center of Cardiology
Author for correspondence.
Email: livbur@mail.ru
Russia, 121552, Moscow
N. V. Lomakin
Central Clinical Hospital of Presidential Administration; Russian Medical Academy of Continuous Professional Education of the Ministry of Health
Author for correspondence.
Email: lomakinnikita@gmail.com
Russia, 119285, Moscow; Russia, 125993, Moscow
E. G. Popov
Chazov National Medical Research Center of Cardiology
Author for correspondence.
Email: info@biola.ru
Russia, 121552, Moscow
A. M. Melkumyants
Chazov National Medical Research Center of Cardiology; Moscow Institute of Physics and Technology (National Research University)
Author for correspondence.
Email: artmelk@gmail.com
Russia, 121552, Moscow; Russia, 141701, Moscow
References
- Аверков О.В., Вечорко В.И., Шапсигова О.А. Должно ли лечение острого инфаркта миокарда во всех случаях начинаться в условиях реанимационных отделений? // Неотложная Кардиол. 2017. № 2. С. 27–42. ISSN: 2413-8991.
- Акчурин Р.С., Василъев В.П., Галяутдинов Д.М., Королев С.В., Лепилин М.Г. с соавт. Современная хирургия коронарных артерий // Кардиол. Вест. 2010. № 1. С. 45. ISSN: 2077-6764eISSN: 2712-889X.
- Алекян Б.Г., Абросимов А.В. Современное состояние рентгенэндоваскулярного лечения острого коронарного синдрома и перспективы его развития в Российской Федерации // Компл. Пробл. Серд.-Сосуд. Заболев. 2013. № 1. С. 5. УДК: 616.127-005.8.
- Алекян Б.Г., Ганюков В.И., Маношкина Е.М., Протопопов А.В., Скрыпник Д.В., Кислухин Т.В. Реваскуляризация при инфаркте миокарда с подъемом сегмента ST в Российской Федерации // Эндоваск. Хир. 2019. Т. 6 № 2. С. 89.https://doi.org/10.24183/2409-4080-2019-6-2-89-97
- Алшибая М.Д. К юбилею операции коронарного шунтирования: еще раз об этой истории, об эмоциональном выгорании и труэнтизме // Креатив. Кардиол. 2017. Т. 11. № 3. С. 202.https://doi.org/10.24022/1997-3187-2017-11-3-202-211
- Бокерия Л.А., Глянцев С.П. Профессор Василий Иванович Колесов: парад приоритетов (к 50-летию первой в мире операции маммарно-коронарного анастомоза и 110-летию со дня рождения ее автора В.И. Колесова) // Анналы Хирур. 2014. № 3. С. 53. УДК 616.132-089 (091) (470+571).
- Бородулин В.И., Тополянский А.В. Этапы становления кардиологии в СССР как самостоятельной области клинической медицины (научно-учебной дисциплины и врачебной специальности) // Клин. Мед. 2012. № 12. С. 74. УДК 616.12-07-08.
- Бородулин И., Тополянский А.В., Пашков К.А. Научная школа клинической кардиологиипрофессора Дмитрия Дмитриевича Плетнёва: новые неизвестные данные. Часть 1 // Креативная Кардиол. 2012. № 2. С. 90. УДК 616.1(091)
- Бурячковская Л.И., Полякова Е.О., Зорин А.В., Учитель И.A. Чазов Е.И. c соавт. Активация тромбоцитов и маркеры воспаления у больных ИБС c депрессивными расстройствами // Тер. Aрхив. 006, № 9. С. 82. УДК: 616.1Z7-00S.4-06 616.89-008.454]-07.
- Вайль С.С. Функциональная морфология. 1960. Ленинград. Медгиз. 239 С.
- Виноградов А.В., Вихерт А.М., Дорофеева З.З., Чазов Е.И. Инфаркт миокарда. 1971 Москва. Медицина, 312 С.
- Житенева Л.Д., Рудницкая О.А., Калюжная Т.И. Эколого-гематологические характеристики некоторых видов рыб. Справочник. Ростов-на-Дону. АзНИИРХ, 1997. 149 с. ISBN 5-86524-023-4.
- Житенева Л.Д., Макаров Э.В., Рудницкая О.А. Тромбоциты рыб и других групп позвоночных. 2003. Р-Дон. Изд-во СКНЦ ВШ, 71 с. ISBN: 5-93365-018-1.
- Замятин М.Н., Линчак Р.М., Карташева Е.Д. Антикоагулянтная терапия при остром коронарном синдроме без подъема сегмента ST на ЭКГ // Трудный пациент. 2009. Т. 7. № 3. С. 5.
- Кардиология в СССР. Под ред. Акад. Е.И. Чазова. 1982. 287 С.
- Колесов В.И. Коронарно-грудной анастомоз как метод лечения коронарной болезни сердца // Клин. Мед. 1966. Т. 7. С. 7
- Кудряшов Б.А. Проблемы свертывания крови и тромбообразования. 1960. Москва. Высшая школа. 244 с.
- Литвинов Р.И., Пешкова А.Д. Контракция (ретракция) сгустков крови и тромбов: патогенетическое и клиническое значение // Альман. Клин. Мед. 2018. Т. 46. № 7. С. 662. https://doi.org/10.18786/2072-0505-2018-46-7-662-671
- Маркосян А.А. Нервная регуляция свертывания крови. 1960. Москва. Изд. Академии педагогических наук, 376 С.
- Маркосян А.А., Ломазова Х.Д., Метальникова Л.М. Нейрогуморальная ирегуляция биосинтеза факторов свертывания и антисвертывания крови в печени // Патол. Физиол. Эксперим. Тер. 1963. № 6. С. 53–57.
- Маркосян А.А. Физиология свертывания крови. 1966. Москва. Медицина, 463 С.
- Образцов В.П., Стражеско Н.Д. К симптомологии и диагностике тромбозов венечных артерий сердца. В книге: Труды 1 съезда Российских терапевтов. 1910. Москва. Товарищество Типографий Мамонтова, С. 26–43.
- Образцов В.П. Избранные труды. Т. 2. Киев, АН УССР. 1950. 308 С.
- Рабкин И.Х., Матевосов А.Л., Готман Л.Н. Рентгеноэндоваскулярная хирургия: Руководство для врачей. 1987. Москва. Медицина, 416 С.
- Руда М., Николаева Л.Ф. Ишемическая болезнь сердца. 1982. С. 162–166. В сб. Кардиология в СССР. Под ред. Е.И. Чазова. АМН СССР. М., Медицина. 288 С.
- Семченко А. Краткая история коронарной хирургии. Москва. ЛитагентЛидеро, 2016. С. 8. 150 с. ISBN. 9785447468309.
- Серебряная Н.Б., Якуцени П.П., Климко Н.Н. Роль тромбоцитов в патогенезе бактериальных инфекций // Журн. Инфектологии. 2017. Т. 9. № 4. С. 5. https://doi.org/10.22625/2072-6732-2017-9-4-5-13
- Серебряная Н.Б., Шанин С.Н., Фомичева Е.Е., Якуцени П.П. Тромбоциты как активаторы и регуляторы воспалительных и иммунных реакций. Часть 2. Тромбоциты как участники иммунных реакций // Мед. Иммунол. 2019. Т. 21. № 1. С. 9. https://doi.org/10.15789/1563-0625-2019-1-9-20
- Сидоренко Б.А., Преображенский Д.В. Клиническое применение антитромботических препаратов. 1997. Москва. Эвтаназия, 176 С. ISBN 5-225-01163-5.
- Смолянников А.В. Труды XIV Всесоюзного съезда терапевтов. 1958. Москва. Медгиз. С. 305–310.
- Струков А.И. (под ред.) Вопросы морфологии и патогенеза инфаркта. 1959. Москва. Медгиз, 259 с.
- Сыркин А.Л., Сазонова Ю.С. Страницы прошлого: госпитализация и режим больных с инфарктом миокарда (к 50-летию блоков кардиореанимации и интенсивной терапии) // Клин. Мед. 2012. Т. 90. № 9. С. 79. УДК 616.127-005.8-082:614.2]:93.
- Фридберг Ч.К. Инфаркт миокарда. Москва. Медицина, 1972. 319 С.
- Чазов Е.И. Тромбозы и эмболии в клинике внутренних болезней. 1966. Москва. Медицина, 263 с.
- Чазов Е.И., Матвеева Л.С., Мазаев А.В., Саргин К.Е., Садовская Г.В. Внутрикоронарное введение фибринолизина при остром инфаркте миокарда. 1976. Тер. Архив. Т. 48. № 4. С. 8.
- Чазов Е.И., Руда М.Я. Развитие основных направлений в лечении больных инфарктом миокарда за последние 25 лет // Кардиол. 1989. № 11. С. 11.
- Чазов Е.И. Пути повышения эффективности лечения больных ИБС // Тер. Архив. 1997. Т. 69. № 9-С. С. 5.
- Alfaddagh A., Martin S.S., Leucker T.M., Michos E.D., Blaha M.J. et al. Inflammation and cardiovascular disease: From mechanisms to therapeutics // Am. J. Prev. Cardiol. 2020. № 4. P. 100130.https://doi.org/10.1016/j.ajpc.2020.100130
- Aschoff L. Introduction. In: Cowdry EV, ed. Arteriosclerosis: A Survey of the Problem. New York. Macmillan, 1933. 18 p.
- Bertrand M. More than 25 years of percutaneous cardiovascular interventions: a historical perspective. In: Handbook of complications during percutaneous cardiovascular interventions. Ed. by Eeckhout E. 2007. London. Informa Healthcare. P. 3–17.
- Bian X., Yin S., Yang S., Jiang X., Wang J. et al. Roles of platelets in tumor invasion and metastasis: A review // Heliyon. 2022. P. e12072.https://doi.org/10.1016/j.heliyon.2022.e12072
- Braunwald E., Antman E.M. Evidence-based coronary care // Annals Intern. Med. 1997. V. 126. № 7. P. 551.https://doi.org/10.7326/0003-4819-126-7-199704010-00009
- Braunwald E. Historical milestones in reperfusion therapy for myocardial infarction. Reperfusion Therapy for Acute Myocardial Infarction. CRC Press. 2016. 17. ISBN 9780429136351.
- Broos K., Feys H.B., De Meyer S.F., Vanhoorelbeke K., Deckmyn H. Platelets at work in primary hemostasis // Blood Rev. 2011. V. 25. P. 155.https://doi.org/10.1016/j.blre.2011.03.002
- Craven L.L. Experience with aspirin in the nonspecific prophylaxis of coronary thrombosis // Mississippi Valley Med. J. 1953. V. 75. P. 38.
- Crowther M.A. Pathogenesis of atherosclerosis //ASH Education Program Book. 2005. V. 2005. № 1. P. 436–441. https://doi.org/10.1182/asheducation-2005.1.436
- Daniel M., Agewall S., Berglund F., Caidahl K., Collste O. et al. Prevalence of anxiety and depression symptoms in patients with myocardial infarction with non-obstructive coronary arteries // Am. J. Med. 2018. V. 131 № 9. P. 1118.https://doi.org/10.1016/j.amjmed.2018.04.040
- Davi., G., Patrono C. Platelet activation and atherothrombosis // New Engl. J. Med. 2007. V. 357. P. 2482. https://doi.org/10.1056/NEJMra071014
- Davizon-Castillo P., Rowley J., Rondina M. Megakaryocyte and platelet transcriptomics for discoveries in human health and disease // Arterioscl. Thromb. Vasc. Biol. 2020. V. 40. № 6. P. 1432.https://doi.org/10.1161/ATVBAHA.119.313280
- De Meyer G.R., De Cleen D.M., Cooper S., Knaapen M.W., Jans D.M. et al. Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis // Circ. Res. 2002. V. 90. № 11. p. 1197.https://doi.org/10.1161/01.res.0000020017.84398.61
- Dotter C.T. Transluminally-placed coilspring endarterial tube grafts: long-term patency in canine popliteal artery // Investigat. Radiol. 1969. V. 4. № 5. P. 329.
- Edelstein L.C., McKenzie S.E., Shaw C., Holinstat M.A., Kunapuli S.P., Bray P.F. MicroRNAs in platelet production and activation // J. Thromb. Haemost. 2013. V. 11 (suppl 1). P. 340.https://doi.org/10.1111/jth.12214
- Eicher J.D., Wakabayashi Y., Vitseva O., Esa N., Yang Y. et. al. Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction // Platelets. 2016. V. 27. № 3. P. 230.https://doi.org/10.3109/09537104.2015.1083543
- Fletcher A.P. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy // Trans. Assoc. Am. Physicians. 1958. V. 71. P. 287.
- Gaspard Ph., Whitin H. The history of coronary angioplasty. FSC 2017. Europa Digital Pblishing, 207 p.
- Gawaz M., Borst O. The role of platelets in atherothrombosis. In: Platelets. Ed: A. Michelson; Academic Press, 2019: P. 459–467. ISBN 978-0-12-8113456-6.
- Gianazza E., Brioschi M., Baetta R., Mallia A. et al. Platelets in healthy and disease states: from biomarkers discovery to drug targets identification by proteomics // Int. J. Mol. Sci. 2020. V. 21. № 12. P. 4541. https://doi.org/10.3390/ijms21124541
- Gibson P. Salicylic acid for coronary thrombosis? // Lancet. 1948. V. 251. № 6512. P. 965
- Gruentzig A.R. Transluminal dilatation of coronary artery stenosis // Lancet. 1978. V. 1. P. 263.https://doi.org/10.1016/s0140-6736(78)93000-3
- Gunnar R.M., Bourdillon P.D., Dixon D.W., Fuster V., Karp R. et al. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction) // J. Amer. Coll. Cardiol. 1990. V. 16. № 2. P. 249.https://doi.org/10.1016/0735-1097(90)90575-A
- Haemmerle M., Stone R.L., Menter D.G., Afshar-Kharghan V., Sood A.K. The platelet lifeline to cancer: challenges and opportunities // Cancer Cell. 2018. V. 33. P. 965. https://doi.org/10.1016/j.ccell.2018.03.002
- Hartzler G.O., Rumerford B.D., McConahay D.R., Johnson Jr W.L., McCallister B.D. et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction // Amer. Heart J. 1983. V. 106. № 5. P. 965. https://doi.org/10.1016/0002-8703(83)90639-7
- Hartwig H., Drechsler M., Lievens D., Kramp B., von Hundelshausen P., et. al. Platelet-derived PF4 reduces neutrophil apoptosis following arterial occlusion // Thromb. Haemost. 2014. V. 111. № 3. P. 562.https://doi.org/10.1160/TH13-08-0699
- Heijnen H., Van Der Sluijs P. Platelet secretory behaviour: as diverse as the granules… or not? // J. Thromb. Haemost. 2015. V. 13. № 12. P. 2141. https://doi.org/10.1111/jth.13147
- Hofvendahl S. Influence of treatment in a coronary care unit on prognosis in acute myocardial infarction. A controlled study in 271 cases // Acta Med. Scandinav. Supplement. 1971. V. 519. P. 9. PMID: .5286521
- Huber K., Bates E.R., Valgimigli M., Wallentin L., Kristensen S. et al. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? // Amer. Heart J. 2014. V. 168. № 5. P. 611. https://doi.org/10.1016/j.ahj.2014.06.014
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 // Lancet. 1988. V. 2. № 8607. P. 349. PMID: .2899772
- Jones D.S. CABG at 50 (or 107?)—the complex course of therapeutic innovation // New Engl. J. Med. 2017. V. 376. № 19. P. 1809.https://doi.org/10.1056/NEJMp1702718
- Julian D.G. The history of coronary care units // Brit. Heart J. 1987. V. 57. №. 6. P. 497.https://doi.org/10.1136/hrt.57.6.497
- Kaiser R., Escaig R., Erber J., Nicolai L. Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease // Front. Cardiovasc. Med. 2022. V. 8. P. 2272.https://doi.org/10.3389/fcvm.2021.824112
- Keltz T.N., Innerfield M., Gitler B., Cooper J.A. Dipyridamole-lnduced myocardial ischemia // Jama. 1987. V. 257. № 11. P. 1515.https://doi.org/10.1001/jama.1987.03390110091034
- Kolessov V.I. Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris // J. Thorac. Cardiovasc. Surg. 1967. V. 54. P. 535.
- Konstantinov I.E. Goetz R. The surgeon who performed the first successful clinical coronary artery bypass operation // Annals Thorac. Surg. 2000.V. 69. № 6. P. 1966.https://doi.org/10.1016/s0003-4975(00)01264-9
- Lambrecht S., Sarkisian L., Saaby L., Poulsen T.S., Gerke O. et al. Different causes of death in patients with myocardial infarction type 1, type 2, and myocardial injury // Amer. J. M. 2018. V. 131. № 5. P. 548–554.https://doi.org/10.1016/j.amjmed.2017.11.043
- Langer H.F., Daub K., Braun G., Schönberger T. et. al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro // Arterioscler. Thromb. Vasc. Biol. 2007. V. 27. № 6. P. 1463.https://doi.org/10.1160/TH13-08-0699
- Li J.L., Zarbock A., Hidalgo A. Platelets as autonomous drones for hemostatic and immune surveillance // J. Experiment. Med. 2017. V. 214. № 8. P. 2193.https://doi.org/10.1084/jem.20170879
- Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis // Nature. 2011. V. 473. № 7347. P. 317.https://doi.org/10.1038/nature10146
- Love B.B., Biller J., Gent M. Adverse haematological effects of ticlopidine // Drug Safety. 1998. V. 19. № 2. P. 89.https://doi.org/10.2165/00002018-199819020-00002
- Magnani G., Bricoli S., Ardissino M., Maglietta G., Nelson A., Tagliazucchi G.M. et al. Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA) // Internat. J. Cardiol. 2022. V. 354. P. 7.https://doi.org/10.1016/j.ijcard.2022.02.015
- Mandel J., Casari M., Stepanyan M., Martyanov A., Deppermann C. Beyond hemostasis: platelet innate immune interactions and thromboinflammation // Int. J. Mol. Sci. 2022. V. 23. P. 3868.https://doi.org/10.3390/ijms23073868
- Manfredi A., Rovere-Querini P., D’Angelo A., Maugeri N. Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps // Pharmacol. Res. 2017. V. 23. P. 146.https://doi.org/10.1016/j.phrs.2016.08.008
- Menter D., Afshar‑Kharghan V., Shen J., Martch S., Maitra A. et al. Of vascular defense, hemostasis, cancer, and platelet biology an evolutionary perspective // Cancer Metast. Rev. 2022. V. 41. P. 147.https://doi.org/10.1007/s10555-022-10019-5
- Michelson A.D., Cattaneo M., Frelinger A., Newman P. (Eds.). Platelets. Fourth edition. 2019. London. Academic press, 1207 p. ISBN 978-0-12-8113456-6.
- Mohan K.V., Rao S.S., Atreya C.D. Antiviral activity of selected antimicrobial peptides against vaccinia virus // Antiviral. Res. 2010. V. 86. № 3. P. 306.https://doi.org/10.1016/j.antiviral.2010.03.012
- Mueller R., Sanborn T. History of Interventional Cardiology // Amer. Heart J. 1995. V. 129. P. 146.https://doi.org/10.1016/0002-8703(95)90055-1
- Novotny J., Chandraratne S., Weinberger T., Philippi V. Stark K. et al. Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation // PLoS One. 2018. V. 13. № 1. P. e0190728.https://doi.org/10.1371/journal.pone.0190728
- Ostermeier B., Soriano-Sarabia N., Maggirwar S.B. Platelet-released factors: their role in viral disease and applications for extracellular vesicle (EV) therapy // Int. J. Mol. Sci. 2022. V. 23. P. 2321.https://doi.org/10.3390/ijms23042321
- Parguiña A., Grigorian-Shamagian L., Agra R., López-Otero D., Rosa I. et al. Variations in platelet proteins associated with st-elevation myocardial infarction novel clues on pathways underlying platelet activation in acute coronary syndromes // Arterioscler. Thromb. Vasc. Biol. 2011. V. 31. № 12. P. 2957.https://doi.org/10.1161/ATVBAHA.111.235713
- Passacquale G., Sharma P., Perera D., Ferro A. Antiplatelet therapy in cardiovascular disease: Current status and future directions // Brit. J. Clin. Pharmacol. 2022. V. 88. № 6. P. 2686.https://doi.org/10.1111/bcp.15221
- Plé H., Maltais M., Corduan A., Rousseau G., Madore F., Provost P. Alteration of the platelet transcriptome in chronic kidney disease // Thromb. Haemost. 2012. V. 108 № 4. P. 605.https://doi.org/10.1160/TH12-03-0153
- Plantureux L., Mège D., Crescence L., Carminita E., Rober S. et al. The interaction of platelets with colorectal cancer cells inhibits tumor growth but promotes metastasis // Cancer Research. 2020. V. 80. № 2. P. 291.https://doi.org/10.1158/0008-5472.CAN-19-1181
- Putot A., Derrida S.B., Zeller M., Avondo A., Ray P. et al. Short-term prognosis of myocardial injury, type 1, and type 2 myocardial infarction in the emergency unit. Am. J. Med. 2018. V. 131. № 10. P.1209.https://doi.org/10.1016/j.amjmed.2018.04.032
- Rendu F., Brohard-Bohn B. The platelet release reaction: granules’ constituents, secretion and functions // Platelets. 2001. V. 12. № 5. P. 261.https://doi.org/10.1080/09537100120068170
- Richter I.H., Cliffton E.E., Epstein S., Musacchio F., Nassar A. et al. Thrombolysin therapy in myocardial infarction // Amer. J. Cardiol. 1962. V. 9. № 1. P. 82.https://doi.org/10.1016/0002-9149(62)90100-5
- Rossaint J., Kühne K., Skupski J., van Aken H., Looney M.R. et al. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response // Nat. Commun. 2016. № 7. P. 13464.https://doi.org/10.1038/ncomms13464
- Ruggeri Z.M., Mendolicchio G.L. Adhesion mechanisms in platelet function // Circ. Res. 2007. V. 100. P. 1673.https://doi.org/10.1161/01.RES.0000267878.97021.ab
- Ryan T.J. Ryan T.J., Anderson J.L., Antman E.M., Braniff B.A. et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) // J. Amer. Coll. Cardiol. 1996. V. 28. № 5. P. 1328.https://doi.org/10.1016/S0735-1097(96)00392-0
- Sakariassen K.S., Orning L., Turitto V.T. The impact of blood shear rate on arterial thrombus formation // Future Science OA. 2015. V. 1. №. 4. P. FSO30.https://doi.org/10.4155/fso.15.28
- Sang Y., Roest M., de Laat B., de Groot P.G., Huskens D. Interplay between platelets and coagulation // Blood reviews. 2021. V. 46. P. 100733.https://doi.org/10.1016/j.blre.2020.100733
- Santoso S., Sachs U.J., Kroll H., Linder M., Ruf A. et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1 // J. Exp. Med. 2002. V. 196. P. 679. https://doi.org/10.1084/jem.20020267
- Schrottmaier W.C., Salzmann M., Badrnya S., Mussbacher M., Kral-Pointner J.B. et al. Platelets mediate serological memory to neutralize viruses in vitro and in vivo // Blood Adv. 2020. V. 4. № 16. P. 3971.https://doi.org/10.1182/bloodadvances.2020001786
- Schwertz H., Tolley N.D., Foulks J.M., Denis M.M., Risenmay B.W. et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J. Exp. Med. 2006. V. 203. № 11. P. 2433. https://doi.org/10.1084/jem.20061302
- Schubert S., Weyrich A.S., Rowley J.W. A tour through the transcriptional landscape of platelets // Blood. 2014. V. 124. P. 493.https://doi.org/10.1182/blood-2014-04-512756
- Sedov V.M., Nemkov A.S. Vasilii Ivanovich Kolesov: pioneer of coronary surgery // Eur. J. Cardio-Thorac. Surg. 2014. V. 45. № 2. P. 220.https://doi.org/10.1093/ejcts/ezt605
- Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game // Nat. Rev. Mol. Cell. Biol. 2010. № 11. P. 288. https://doi.org/10.1038/nrm2871
- Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L. Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty // New Engl. J. Med. 1987. V. 316. № 12. P. 701.https://doi.org/10.1056/NEJM198703193161201
- Smyth S.S., McEver R.P., Weyrich A.S., Morrell C.N., Hoffman M.R. et al. Platelet Colloquium Participants. Platelet functions beyond hemostasis // J. Thromb. Haemost. 2009. № 7. P. 1759.https://doi.org/10.1111/j.1538-7836.2009.03586.x
- Teixeira R., Goncalves L., Gersh B. Acute myocardial infarction – historical notes // Internat. J. Cardiol. 2013. V. 167. № 5. P. 1825.https://doi.org/10.1016/j.ijcard.2012.12.066
- Thomas M.R., Storey R.F. Platelets in acute coronary syndromes. Platelets in Thrombotic and Non-Thrombotic Disorders. – Springer, Cham, 2017. P. 1015–1028.https://doi.org/10.1007/978-3-319-47462-5_67
- Thomas S.G. The structure of resting and activated platelets. A.D. Michelson (Ed.) // Platelets. 2019. P. 47. ISBN 978-0-12-8113456-6.
- Thygesen K, Alpert J., Jaffe A., Simoons M., Chaitman B. et al. Third Universal Definition of Myocardial Infarction // Circulation. 2012. V. 126. P. 2020.https://doi.org/10.1016/j.gheart.2012.08.001
- Timmis A., Townsend N., Gale C., Grobbee R., Maniadakis N. et al. European Society of Cardiology: cardiovascular disease statistics 2017 // Eur. Heart J. 2017. V. 39. № 7. P. 508.https://doi.org/10.1093/eurheartj/ehx628
- Tomasik A.B. Thrombocyty ryb kostnoszkieletowich // Prz Zool. 1972. V. 16. № 2. P. 173.
- Yang J., Furie B.C., Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction // Thromb. Haemost. 1999. V. 81. № 01. P. 1. https://doi.org/10.1055/s-0037-1614407
- Ulrichts H., Udvardy M.S., Lenting P.J., Pareyn I., Vandeputte N. et al. Shielding of the A1 domain by the D ’ D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V // J. Biol. Chem. 2006. V. 281. P. 4699.https://doi.org/10.1074/jbc.M513314200
- van der Meijden P., Heemskerk J. Platelet biology and functions: new concepts and clinical perspectives // Nat. Rev. Cardiol. 2019. V. 16. P. 166.https://doi.org/10.1038/s41569-018-0110-0
- Van Nostrand W., Schmaier A., Farrow J., Cunningham D. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein // Science. 1990. V. 248. № 4956. P. 745.https://doi.org/10.1126/science.2110384
- Velez P., García A. Platelet proteomics in cardiovascular diseases // Transl. Proteomics. 2015. № 7. P. 15.https://doi.org/10.1016/j.trprot.2014.09.002
- Vélez P., Ocaranza‐Sánchez R., López‐Otero D., Grigorian‐Shamagian L., et. al. 2D‐DIGE‐based proteomic analysis of intracoronary versus peripheral arterial blood platelets from acute myocardial infarction patients: Upregulation of platelet activation biomarkers at the culprit site // PROTEOMICS–Clinical Applications. 2016. V. 10. № 8. P. 851. https://doi.org/10.1002/prca.201500120.
- Villavicencio J.L., Warren R. Experience with the use of human fibrinolysin // Angiol. 1959. V. 10. № 4. P. 263.https://doi.org/10.1177/000331975901000
- Volpi E., Giusti L., Ciregia F., Da Valle Y., Giannaccini G. et al. Platelet proteome and clopidogrel response in patients with stable angina under- going percutaneous coronary intervention // Clin. Biochem. 2012. V. 45. P. 758.https://doi.org/10.1016/j.clinbiochem.2012.03.028
- Warshaw A.L., Laster L., Shulman N.R. Protein synthesis by human platelets // J. Biol. Chem. 1967. V. 242. № 9. P. 2094. PMID: .6022853
- Weaver W.D. Time to thrombolytic treatment: factors affecting delay and their influence on outcome // J. Amer. Coll. Cardiol. 1995. V. 25. № 7 Suppl. P. S3.https://doi.org/10.1016/0735-1097(95)00108-G
- Weyrich A.S., Zimmerman G.A. Platelets in lung biology // Annu. Rev. Physiol. 2013. V. 75. P. 569.https://doi.org/10.1146/annurev-physiol-030212-183752
- Wicik Z., Czajka P., Eyileten C., Fitas A., Wolska M., Jakubik D. et al. The role of miRNAs in regulation of platelet activity and related diseases-a bioinformatic analysis // Platelets. 2022. V. 33. № 7. P. 1052.https://doi.org/10.1080/09537104.2022.2042233
- Wood J.P., Fager A.M., Silveira J.R., Tracy P.B. Platelet-derived factor Va expressed on the surface of the activated platelet is GPI-anchored // Blood. 2008. V. 112. P. 219.https://doi.org/10.1182/blood.V112.11.585.585
- Wu T., Chen L., Zhou L., Xu J., Guo K. Platelets transport β-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer’s disease in mouse models // Aging (Albany NY). 2021. V. 13. № 5. P. 7644.https://doi.org/10.18632/aging.202662
- Yusuf S., Zucker D., Passamani E., Peduzzi P., Takaroet T. et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration // Lancet. 1994. V. 344. № 8922. P. 563. https://doi.org/10.1016/S0140-6736(94)91963-1